Positive clinical trial results often lead to increased product adoption and can significantly impact a company's financial performance by opening up new markets or strengthening its position in existing ones. Given the chronic nature of Multiple Sclerosis and the need for effective treatments, Zeposia's demonstrated long-term efficacy and safety could result in increased sales and a stronger competitive stance for Bristol Myers Squibb in this therapeutic area.